HIV Prevention

;

Don’t reverse America’s progress against HIV

by | Nov 21, 2025

It bears remembering that the United States has made tremendous strides against HIV in recent years. From 2018 to 2022, new infections declined by 12% nationwide–and by 21% in the communities targeted by the Ending the HIV Epidemic initiative. However, there were still 39,000 new diagnoses in 2023, with over half of them in the South. Eliminating HIV prevention funding now would squander that progress and contradict President Trump’s original commitment to end HIV by 2030. In fact, earlier this fall, National Institutes of Health Director Jay Bhattacharya reaffirmed that goal, noting the elimination of HIV as one of his top priorities. These devastating proposed cuts would make that impossible to achieve.

read more

Biden-Harris must ensure access to HIV prevention drugs

by | Oct 6, 2024

The Biden-Harris administration has a historic opportunity to help end HIV. New, cutting-edge drugs that prevent HIV are hitting the market, but insurance companies are trying to twist the rules to deny access to these remarkable therapies. The White House could stop these abuses and put the country on the right course for decades ahead and prevent hundreds of thousands of new HIV transmissions.

read more

Congress must not miss an opportunity to end HIV

by | Nov 30, 2023

Despite the Republican-led success against HIV, some House Republicans have been considering a spending bill that would cut funding for HIV prevention and treatment. Such cuts would not only lead to more preventable infections and deaths — they’d result in more long-term spending by American taxpayers. We have the tools to end HIV. We must not abandon our efforts nor the people and communities most impacted by this potentially deadly infectious disease.

read more

It is possible to end HIV in the United States within the next decade – lawmakers must make it a reality

by | Jun 1, 2023

We believe congressional authorization for a new government program is unlikely in the near term, given the program’s price tag and its reliance on a centralized mechanism for purchasing drugs and laboratory services.
A more realistic approach, given these constraints, is for Congress to increase funding at the CDC along with targeted grants to community health centers and Ryan White Program clinics, particularly those that can most effectively increase PrEP uptake among Blacks and Latinos and in the South. It’s possible to end HIV in the United States within the next decade. Lawmakers must act to make it a reality.

read more

Congress, don’t cut funding for HIV programs

by | May 25, 2023

Over the next few months, congressional appropriation committee leaders will have to hash out spending levels for individual government programs. President Joe Biden’s budget takes an enormous step toward meeting the nation’s goal of ending the HIV epidemic by 2030 through substantially increasing funding for HIV treatment and prevention programs. Some in Congress seem set on slashing spending. And that means domestic HIV funding could be on the chopping block. That’s a tragedy—one that could jeopardize our progress in the fight against the virus.

read more

Search

Categories

Tags

ACA Appropriations Biden administration CDC Congress Copay accumulators Copay assistance Cost-sharing COVID-19 Drug Pricing Gay men healthcare Hepatitis Hepatitis B Hepatitis C HIV HIV Prevention insurer Insurers Medicaid Medicare Part D PBMs PrEP Prescription Drugs President Biden Private Insurance Testing Treatment Trump administration

Recent Opinion Pieces

Pin It on Pinterest